Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Non-Current Assets (2020 - 2026)

Design Therapeutics' Non-Current Assets history spans 2 years, with the latest figure at $5.1 million for Q4 2021.

  • On a quarterly basis, Non-Current Assets rose 1709.89% to $5.1 million in Q4 2021 year-over-year; TTM through Dec 2021 was $10.6 million, a N/A change, with the full-year FY2021 number at $5.1 million, up 1709.89% from a year prior.
  • Non-Current Assets hit $5.1 million in Q4 2021 for Design Therapeutics, up from $5.1 million in the prior quarter.
  • Over the last five years, Non-Current Assets for DSGN hit a ceiling of $5.1 million in Q4 2021 and a floor of $100000.0 in Q1 2021.